Replies to post #7640 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Update on Biolex’s Locteron program:
#msg-26612906.

[DewDiligence]

Biolex

[Added item on Merck KGaA collaboration.]

Biolex has a production platform for protein drugs that uses transgenic plants. Here's a partial list of relevant posts:

#msg-25179852 Anti-CD20 (Rituxan FoB) program
#msg-26942457 Antibody collaboration with Merck KGaA
#msg-26612906 Locteron program in HCV
#msg-26487825 IPO withdrawal
#msg-21229000 BLX-155 clot-buster program
#msg-19450622 Collaboration with Genmab
#msg-15116312 Homogeneity of glycosylation
#msg-5919466 ‘Plantibody’ patent